10X Genomics Inc (TXG) — Technical state
As of 2026-09-17 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.
Trades +37.4% vs the 50-day and +148% vs the 200-day average, 3.7% below the 52-week high and +589.7% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+16.6%
- vs 50-day+37.4%
- vs 200-day+148%
- 52-week band3.7% off the high · +589.7% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed up through the 50-day 84 sessions ago
- Stochastic%K 86 · %D 87.6 · bear cross
Continue: the TXG chart & overview · the signal board
FAQ · from the current data · as of 2026-09-17
Quick answers
What is the current Closelook signal on TXG?
Uptrend stack intact — Trades +37.4% vs the 50-day and +148% vs the 200-day average, 3.7% below the 52-week high and +589.7% off the 52-week low. Computed from daily closes. As of 2026-09-17; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is TXG above its 50-day and 200-day moving averages?
As of 2026-09-17, 10X Genomics Inc trades +37.4% above its 50-day and +148% above its 200-day average, with the 20-day +16.6% away.
How far is TXG from its 52-week high?
3.7% below the 52-week high and 589.7% above the 52-week low, as of 2026-09-17.
Mentioned on Closelook
Where TXG appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelook universe
then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- SECT-B.ST Sectra AB (publ)industry
- SNN Smith & Nephew SNATS Incindustry
- SOON.SW Sonova H Agindustry
- CEVI.ST CellaVision ABindustry
- SYK Stryker Corporationindustry
- SHL.DE Siemens Healthineers AGindustry
- BIO Bio-Rad Laboratories Incindustry
- BRKR Bruker Corporationindustry
- DXCM DexCom Incindustry
- MDT Medtronic PLCindustry
- NVCR Novocure Ltdindustry
- EW Edwards Lifesciences Corpindustry
- ZBH Zimmer Biomet Holdings Incindustry
- CERS Cerus Corporationindustry
- GKOS Glaukos Corpindustry
- IART Integra LifeSciences Holdingsindustry
- PACB Pacific Biosciences of Californiaindustry
- PEN Penumbra Incindustry
- ABT Abbott Laboratoriesindustry
- GEHC GE HealthCare Technologies Inc.industry